Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.41 |
| ▸ | TSPO | P30536 | 1/20 | 0.39 |
| ▸ | DRD3 | P35462 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.37 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30409781 | 1.00 | ALDH1A1 (0.47) | ALDH1A1HPGDCYP19A1SMN1; SMN2TSHR | |
| SCHEMBL28463170 | 0.90 | ALDH1A1 (0.46) | ALDH1A1HPGDCYP19A1SMN1; SMN2TSHR | |
| SCHEMBL28817550 | 0.82 | ALDH1A1 (0.44) | ALDH1A1HPGDCYP19A1SMN1; SMN2TSHR | |
| SCHEMBL4797057 | 0.82 | CYP19A1 (0.43) | ALDH1A1CYP19A1SMN1; SMN2TSHRMAPT | |
| SCHEMBL29809738 | 0.82 | ALDH1A1 (0.56) | ALDH1A1HPGDTSHRMAPTFFAR1 | |
| SCHEMBL1945874 | 0.82 | ALDH1A1 (0.56) | ALDH1A1HPGDTSHRMAPTFFAR1 | |
| SCHEMBL2153612 | 0.80 | CYP19A1 (0.48) | ALDH1A1HPGDCYP19A1SMN1; SMN2TSHR | |
| SCHEMBL2154210 | 0.80 | SMN1; SMN2 (0.49) | ALDH1A1HPGDCYP19A1SMN1; SMN2TSHR | |
| SCHEMBL24108195 | 0.79 | ALDH1A1 (0.38) | ALDH1A1HPGDCYP19A1SMN1; SMN2TSHR | |
| SCHEMBL24108467 | 0.79 | ALDH1A1 (0.38) | ALDH1A1HPGDCYP19A1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2382241-B1 | POLYMERS FUNCTIONALIZED WITH POLYCYANO COMPOUNDS | BRIDGESTONE CORP (JP) | 2016-11-23 | — | — | EP | claimed |
| US-20150133628-A1 | POLYAMINE AND METHOD FOR PRODUCING THEREOF | RHODIA OPERATIONS (FR) | 2015-05-14 | — | — | US | claimed |
| US-8785566-B2 | Polymers functionalized with polycyano compounds | BRIDGESTONE CORPORATION (JP) | 2014-07-22 | — | — | US | claimed |
| US-20130123542-A1 | POLYAMINE AND METHOD FOR PRODUCING THEREOF | RHODIA OPERATIONS (FR) | 2013-05-16 | — | — | US | claimed |
| EP-2522688-A1 | POLYAMINE AND METHOD FOR PRODUCING THE SAME | Rhodia Operations (FR) | 2012-11-14 | — | — | EP | claimed |
| US-20230389414-A1 | ORGANIC COMPOUNDS AND USES THEREOF IN ORGANIC ELETRONIC DEVICES | Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) | 2023-11-30 | — | — | US | disclosed |
| CN-111757940-B | Microbiological method for producing amides | 哥伦比亚有限公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-116621764-A | Preparation method of 3, 3-dimethyl-6-nitro-1, 3-indoline-2-ketone | 南京合巨药业有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-116199651-A | Preparation method of 2- (1-cyanocyclopropyl) -4, 5-dihydrofuran-3-carbonitrile | 上海毕得医药科技股份有限公司 | 2023-06-02 | — | — | CN | disclosed |
| CN-115724795-A | Amino isoquinoline derivative and application thereof | 江苏欧威医药有限公司 | 2023-03-03 | — | — | CN | disclosed |
| US-20230023009-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | SPARCBIO LLC | 2023-01-26 | — | — | US | disclosed |
| US-20230023009-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | SPARCBIO LLC | 2023-01-26 | — | — | US | disclosed |
| US-5071440-A | Azo-methine and indophenol dyes oxyalkylated by ethylene and/or propylene oxide and/or glycidol; acidolysis; cleavage/C-N/ | MILLIKEN RESEARCH CORPORATION A CORPORATION OF SSC | 1991-12-10 | — | — | US | disclosed |
| US-4963686-A | INTERMEDIATES FOR INOTROPIC AGENTS | BOEHRINGER MANNHEIM GMBH (DE) | 1990-10-16 | — | — | US | disclosed |
| EP-0167045-A1 | Benzo[c][1,8]naphthyridines, process for their preparation and their use, and compositions containing these compounds | Beiersdorf Aktiengesellschaft (DE) | 1986-01-08 | — | — | EP | disclosed |
| US-4369322-A | WITH CYANOGEN CHLORIDE | DEGUSSA AG (DE) | 1983-01-18 | — | — | US | disclosed |
| US-3962307-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3962307-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3962307-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
| US-3877927-A | Herbicidal compositions and methods | DU PONT | 1975-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230389414-A1 | ORGANIC COMPOUNDS AND USES THEREOF IN ORGANIC ELETRONIC DEVICES | SLCO2B1, SLCO2A1, SLCO1B3 | ALDH1A1 245/4885HPGD 2323/4885CYP19A1 43/4885 |
| US-20230023009-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | KRAS, NRAS, HRAS | ALDH1A1 2350/4885HPGD 319/4885CYP19A1 3122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.